Pancreatic Adenocarcinoma Clinical Trials

ReadTheTrial indexes 1 studies for Pancreatic Adenocarcinoma. The most common development stage is Phase 1 (1 trials). Each trial page translates ClinicalTrials.gov eligibility, outcomes, and design into patient-friendly language so you can compare options quickly.

1 clinical trials found for Pancreatic Adenocarcinoma.

Pipeline by Phase

PhaseTrialsDistribution
Phase 1 1
100%

Trial Status Breakdown

Trials for Pancreatic Adenocarcinoma

A Phase I Study of Anetumab Ravtansine in Combination With Either Anti-PD-1 Antibody, or Anti-CTLA4 and Anti-PD-1 Antibodies or Anti-PD-1 Antibody and Gemcitabine in Mesothelin-Positive Advanced Pancreatic Adenocarcinoma

NCT03816358 · ACTIVE NOT RECRUITING · Phase 1

Frequently Asked Questions

What clinical trials are available for Pancreatic Adenocarcinoma?

There are 1 clinical trials listed for Pancreatic Adenocarcinoma. These span various phases from early safety studies to post-approval monitoring. Browse the trial listings below for details.

How do I find recruiting Pancreatic Adenocarcinoma trials?

Look for trials with "Recruiting" status in the listings below, or visit our recruiting page to filter by condition. Each trial page includes decoded eligibility criteria to help you determine if you qualify.

What phases are Pancreatic Adenocarcinoma trials in?

Current Pancreatic Adenocarcinoma trials are distributed across: Phase 1 (1).

Find More Trials